Stephen Liu
MD
Chief of Hematology and Oncology, Associate Professor of Medicine
Georgetown University Hospital
Lombardi Comprehensive Cancer Center
Nov 30, 2023
Episode
190
Soundcloud
Share
Lung Cancer Considered host Dr. Stephen Liu moderates a discussion on the November 15, 2023, US FDA approval of repotrectinib for advanced NSCLC with a ROS1 gene fusion based on the single-arm, multi-cohort TRIDENT-1 trial.
Guest
Jessica Lin
MD
Assistant Professor of Medicine
Harvard Medical School
Belinda Termeer Center for Targeted Therapies at Massachusetts General Hospital
Benjamin Besse
MD, PhD
Director of Clinical Research
Gustave Roussy, Villejuif, France
